Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that specific itchy skin diseases during pregnancy have varying fetal risks and treatments, including corticosteroids and other medications.

Platelet-rich plasma might help tissue regeneration in dentistry, but results vary and more research is needed.

To diagnose hair loss, use a systematic approach including history, exams, and tests.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

The document concludes that hirsutism is the main sign for diagnosing hyperandrogenism, which requires a detailed patient history and physical exam.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Many COVID-19 survivors experience long-term symptoms like fatigue and sleep issues, needing ongoing medical support.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Stress hormone corticosterone blocks a growth factor to slow down hair stem cell activity and hair growth.

Menopause reduces skin collagen and elasticity, and while estrogen therapy can help, its risks require careful consideration.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

Hormonal treatments can help with acne but are not the first choice due to side effects and the need for careful patient selection.

The conclusion is that certain scalp tissue changes are characteristic of lichen planopilaris, with mucinous perifollicular fibroplasia being a new feature for diagnosis.

Myo-inositol may be more effective than metformin for inducing ovulation in women with PCOS.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

Some heart drugs show promise for other conditions, but more research is needed to confirm their effectiveness and safety.

PCOS is a common hormonal disorder in women, treated with lifestyle changes and medications like hormonal contraceptives and metformin.

Iron deficiency common in women, not always linked to hair loss; more research needed.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Advanced hydrogel systems with therapeutic agents could greatly improve acute and chronic wound treatment.

Light and laser therapies show promise for treating Acne Keloidalis Nuchae, but more research is needed.

Red ginseng may improve immunity, fatigue, memory, blood circulation, and menopausal symptoms, and is generally safe to consume.

Some plant-based treatments can help with benign prostatic hyperplasia symptoms, but more research is needed to confirm their safety and effectiveness.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Baricitinib is effective and safe for treating severe alopecia areata.

Dermoscopy improves diagnosis and treatment monitoring for children's skin infections, inflammations, and hair disorders.

The document concludes that early recognition and treatment of primary cicatricial alopecia is crucial to prevent permanent hair loss.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.